Viruses have long been suspected as a cause of Chronic Fatigue Syndrome or CFS, but research studies have been mixed, in part because we lack the tools to detect the viruses we suspect.

The sudden onset of CFS in some patients with an “infectious-like” illness, the nature of some of the symptoms, and the state of chronic immune activation suggest that chronic fatiguing illnesses can be triggered and perpetuated by a virus. CFS symptoms have been described in a variety of acute infections (Leventhal et al., 1991; Rosene et al., 1982; Cluff et al., 1959; Salit, 1985.). Many investigators have reported enteroviral infections in CFS (Cunningham et al., 1990; Gow et al., 1991, 1996; Bowles et al., 1993; Clements et al., 1995; Richardson, 1995; Richardson, 1995; Soteriou et al., 1996). Also, a number of studies have suggested that parvovirus can produce CFS (Kerr et al., 2001, 2002; Matano et al., 2003).

A recent observational study has confirmed the existence of a post-infectious fatigue syndrome and provided clues as to its etiology. Hickie and colleagues identified all cases of acute infection with Epstein-Barr virus (a DNA virus),


Summary from 2008 Symposiumon Viruses in CFS
More information on HHV-6 in CFS
Ross River virus (an RNA virus), and Coxiella burnetii in one township in rural Australia (Hickie et al., 2006). The study involved 253 patients and found that post-infectious fatigue syndrome was present in 12% of the patients six months after their acute infection. Virtually all the patients met the CDC criteria for CFS. Other studies have shown that antiviral pathways are activated in CFS patients (Suhadolnik 1997, Gow 2001). Gene expression profiling has found an up-regulation of mitochondrial translation initiation factor EIF4G1, which is consistent with persistent viral infection (Kerr 2005).

CFS has been associated with reduced NK cell activity, reduced TH1 cell activity, activated TH2 and increased Tc cell activity, all findings consistent with long-term viral infections. (Komaroff, 2006)

Also, viral infections reduce blood fatty acid levels, which are reduced in patients with CFS (Puri 2006). Finally, antiviral treatments (Ampligen, Isoprinosine, beta interferon, valganciclovir) have been somewhat effective in small studies (Strayer, 1994, Newport Pharmaceuticals; See, 1996; Montoya 2006).
For more information contact info@vicd.info   

 

WHAT IS VIRUS INDUCED CNS DYSFUNCTION | STANFORD CLINICAL TRIAL OF VALCYTE IN CFS | RESEARCH ON VIRUSES IN CFS | TESTING | LINKS

optimized & designed by trafficdeveloper